Three‑dimensional culture of tumor cells (Review)

While conventional two-dimensional (2D) cell cultures and animal models have been cornerstone technologies in cancer research, they possess limitations in replicating human tumor pathophysiology. Notably, 2D models fail to capture key tissue-level architecture and cell-cell interactions, whereas animal models are often constrained by species-specific discrepancies and high costs, which limits their applicability in investigating precise human tumor mechanisms. To overcome these shortcomings, three-dimensional (3D) tumor models have emerged as a powerful complementary platform. The present review comprehensively explores the unique capabilities of 3D models in maintaining tumor heterogeneity, simulating the dynamic tumor microenvironment and accelerating high-throughput drug screening. The present review also highlights the transformative potential of 3D models in personalized medicine and in deciphering the mechanisms underlying metastasis. Finally, the present review proposes a visionary roadmap for <i>in vitro</i> 3D model innovation, with the goal of guiding their effective translation from foundational research to clinical decision-making in the future.

Authors

Institutions

Publication Details

Journal
Oncology Letters
Published
2026-01-15
DOI
https://doi.org/10.3892/ol.2026.15464
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Three‑dimensional culture of tumor cells (Review)

Shiyao Du, Haifeng Wang, Jinyu Yang, Dongping Xu et al.
Oncology Letters
3D Printing in Biomedical Research
article

Three‑dimensional culture of tumor cells (Review)

Shiyao Du, Haifeng Wang, Jinyu Yang, Dongping Xu, Shanshan Men, Hui Li
article en

Abstract

While conventional two-dimensional (2D) cell cultures and animal models have been cornerstone technologies in cancer research, they possess limitations in replicating human tumor pathophysiology. Notably, 2D models fail to capture key tissue-level architecture and cell-cell interactions, whereas animal models are often constrained by species-specific discrepancies and high costs, which limits their applicability in investigating precise human tumor mechanisms. To overcome these shortcomings, three-dimensional (3D) tumor models have emerged as a powerful complementary platform. The present review comprehensively explores the unique capabilities of 3D models in maintaining tumor heterogeneity, simulating the dynamic tumor microenvironment and accelerating high-throughput drug screening. The present review also highlights the transformative potential of 3D models in personalized medicine and in deciphering the mechanisms underlying metastasis. Finally, the present review proposes a visionary roadmap for <i>in vitro</i> 3D model innovation, with the goal of guiding their effective translation from foundational research to clinical decision-making in the future.

Oncology LettersVol. 31(3)
Shenyang University of Chemical Technology (CN)
Department of Education of Liaoning Province
Industry, innovation and infrastructure
Openalex Percentile: Top 86%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.